Human exposure to the metal lead (Pb) is prevalent and associated with adverse neurodevelopmental and neurodegenerative outcomes. Pb disrupts normal brain function by inducing oxidative stress and neuroinflammation, altering cellular metabolism, and displacing essential metals. Prior studies on the molecular impacts of Pb have examined bulk tissues, which collapse information across all cell types, or in targeted cells, which are limited to cell autonomous effects. These approaches are unable to represent the complete biological implications of Pb exposure because the brain is a cooperative network of highly heterogeneous cells, with cellular diversity and proportions shifting throughout development, by brain region, and with disease. New technologies are necessary to investigate whether Pb and other environmental exposures alter cell composition in the brain and whether they cause molecular changes in a cell-type-specific manner. Cutting-edge, single-cell approaches now enable research resolving cell-type-specific effects from bulk tissues. This article reviews existing Pb neurotoxicology studies with genome-wide molecular signatures and provides a path forward for the field to implement single-cell approaches with practical recommendations.
Keyphrases
- single cell
- heavy metals
- rna seq
- induced apoptosis
- oxidative stress
- white matter
- high throughput
- genome wide
- resting state
- aqueous solution
- cerebral ischemia
- cell cycle arrest
- risk assessment
- health risk assessment
- cell therapy
- gene expression
- endothelial cells
- functional connectivity
- healthcare
- emergency department
- randomized controlled trial
- single molecule
- stem cells
- health risk
- systematic review
- traumatic brain injury
- endoplasmic reticulum stress
- air pollution
- dna damage
- dna methylation
- diabetic rats
- ischemia reperfusion injury
- case control
- mesenchymal stem cells